HRT Financial’s Catheter Precision VTAK Stock Holding History
Bought
Maintained
Sold
Other funds holding VTAK
VF
TRCT
AF
PUI
HI
SS
HRT Financial's VTAK Position: Q2 2026 in Review
HRT Financial sold out of Catheter Precision (VTAK) in Q2 2026, closing a stake of 11,276 shares — an estimated $11K sold.
HRT Financial first reported a position in VTAK in Q3 2022 and held it in 4 quarters. The position peaked at $42K in Q2 2025. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.
- HRT Financial reported no remaining Catheter Precision position as of Q2 2026 after selling out during the quarter.
- HRT Financial sold 11,276 Catheter Precision shares in Q2 2026, an estimated $11K.
- HRT Financial first reported a position in Catheter Precision in Q3 2022 and held it in 4 quarters.
- HRT Financial's Catheter Precision position peaked at $42K in Q2 2025.
- 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.
Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.